Compass Therapeutics' Series A - IV Round

Compass Therapeutics raised a round of funding on January 08, 2018.

Compass Therapeutics, formerly Kairos Biologics Foundation, is comprehensively drugging the tumor-immune synapse with human antibodies against cell surfaces and soluble targets.…

Articles about Compass Therapeutics' Series A - IV Round: